ChrysCapital announces investment in Linux Laboratories

ChrysCapital announced its investment in Linux Laboratories, an Indian domestic formulations business with a focus on central nervous system therapies. The firm said it would support the company’s next phase of growth. Transaction adviser Avendus separately reported a combined USD 70 million investment from ChrysCapital and Tata Capital Healthcare Fund. Individual investor contributions were not disclosed.